Somnomed Ltd
F:RJV

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
F:RJV
Watchlist
Price: 0.422 EUR -4.09%
Market Cap: 91.2m EUR
Section:
 

Relative Value

The Relative Value of one RJV stock under the Base Case scenario is hidden EUR. Compared to the current market price of 0.422 EUR, Somnomed Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RJV Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
53
vs Industry
61
Median 3Y
1.2
Median 5Y
1.5
Industry
2.3
Forward
1.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-16.6
Median 5Y
-32.2
Industry
22.5
Forward
49.8
More Details
20.7
P/OCF
P/OCF
Price to OCF
20.7
vs History
49
vs Industry
5
Median 3Y
-5.2
Median 5Y
20.8
Industry
14.4
More Details
211.8
P/FCFE
P/FCFE
Price to FCFE
211.8
vs History
19
vs Industry
Median 3Y
-1.3
Median 5Y
-4.6
Industry
21.4
More Details
3.5
P/B
P/B
Price to Book Value
3.5
vs History
65
vs Industry
34
Median 3Y
3
Median 5Y
4
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
57
vs Industry
66
Median 3Y
1.1
Median 5Y
1.4
Industry
2.5
Forward
1.2
More Details
2.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.2
vs History
57
vs Industry
72
Median 3Y
1.8
Median 5Y
2.4
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-28.5
Median 5Y
-40.8
Industry
11.9
Forward
13.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-28.5
Median 5Y
-40.8
Industry
16.8
Forward
35.2
More Details
19.2
EV/OCF
EV/OCF
Enterprise Value to OCF
19.2
vs History
49
vs Industry
7
Median 3Y
-3.4
Median 5Y
19.3
Industry
14.5
More Details
39.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
39.2
vs History
20
vs Industry
Median 3Y
-6.2
Median 5Y
-8.8
Industry
18.6
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
53
vs Industry
31
Median 3Y
2.7
Median 5Y
3.6
Industry
1.9
More Details

Multiples Across Competitors

RJV Competitors Multiples
Somnomed Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Somnomed Ltd
F:RJV
161m EUR 1.4 -46.6 -517.5 -517.5
US
Abbott Laboratories
NYSE:ABT
219.4B USD 5 15.7 20 27.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
209.7B USD 21.8 76.4 58.6 71.5
US
Boston Scientific Corp
NYSE:BSX
145.8B USD 7.5 52.2 30.5 41.5
US
Stryker Corp
NYSE:SYK
140.4B USD 5.8 47.7 23.2 28.1
IE
Medtronic PLC
NYSE:MDT
126.5B USD 3.6 26.6 14.9 21.6
DE
Siemens Healthineers AG
XETRA:SHL
52B EUR 2.2 24.3 13.6 19.2
US
Becton Dickinson and Co
NYSE:BDX
58.6B USD 2.7 34.9 12.8 21.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57B USD 13.7 55.5 39.8 44.1
US
Edwards Lifesciences Corp
NYSE:EW
49.1B USD 8.3 35.9 25.7 28.1
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
40.2B USD 2 18.1 13.4 16.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Somnomed Ltd
F:RJV
Average EV/EBITDA: 25.3
Negative Multiple: -517.5 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
20
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.6
26%
2.3
US
Boston Scientific Corp
NYSE:BSX
30.5
22%
1.4
US
Stryker Corp
NYSE:SYK
23.2
13%
1.8
IE
Medtronic PLC
NYSE:MDT
14.9
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.6
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.8
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.8
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.7
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
13.4
10%
1.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Somnomed Ltd
F:RJV
Average EV/EBIT: 32
Negative Multiple: -517.5 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
27.8
22%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
71.5
28%
2.6
US
Boston Scientific Corp
NYSE:BSX
41.5
32%
1.3
US
Stryker Corp
NYSE:SYK
28.1
16%
1.8
IE
Medtronic PLC
NYSE:MDT
21.6
17%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.2
15%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.8
21%
1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1
15%
2.9
US
Edwards Lifesciences Corp
NYSE:EW
28.1
13%
2.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
16.2
12%
1.4

See Also

Summary
RJV intrinsic value, competitors valuation, and company profile.
DCF Valuation
RJV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RJV stock valuation using valuation multiples.
Wall Street Estimates
RJV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RJV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.